维普中文期刊产品整合服务
39篇 您的检索式:作者名="Ference F"
    题名 作者 年代 出处 被引量
1Epithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: Clinico-pathogenic aspects显示文摘Toll-like receptors (TLRs) recognize specific motifs which are frequently present in bacteria, fungi, prokaryotes and viruses. Amongst TLRs, TLR9 can be activated by such bacterial or viral DNA fragments, immunoglobulin-DNA complexes or synthetic oligonucleotides, which all contain unmethylated cytosineguanine nucleotide sequences (CpGs). Emerging data indicate that TLR9 signaling has a role in, and may influence, colorectal carcinogenesis and colonic inflammation. CpGs are classified into three groups according to their influence on both the antigen-specific humoraland cellular immunity, and the production of type 1 interferons and proinflammatory cytokines. TLR9 activation via CpGs may serve as a new therapeutic target for several cancerous and various inflammatory conditions. Due to its probable anti-cancer effects, the application possibilities of TLR9-signaling modulation may be extremely diverse even in colorectal tumors. In this review we aimed to summarize the current knowledge about TLR-signaling in the pathogenesis and therapy of inflammatory bowel diseases and colorectal cancer. Due to the species-specific differences in TLR9 expression, however, one must be careful in translating the animal model data into the human system, because of the differences between CpG-oligodeoxynucleotide-responsive cells. TLR9 agonist DNA-based immunomodulatory sequences could also represent a promising therapeutic alternative in systemic inflammatory conditions and chronic colonic inflammations as their side effects are not significant.István Fri Ferenc Sipos Tiana M Germann Alexandra Kalmár Zsolt Tulassay Béla Molnár Gyrgyi Mzes 2013World Journal of Gastroenterology2013,19,26:14
2Contribution of TLR signaling to the pathogenesis of colitisassociated cancer in inflammatory bowel disease显示文摘In the intestine a balance between proinflammatory and repair signals of the immune system is essential for the maintenance of intestinal homeostasis. The innate immunity ensures a primary host response to microbial invasion, which induces an inflammatory process to localize the infection and prevent systemic dissemination of pathogens. The key elements of this process are the germline encoded pattern recognition receptors inclu-ding Toll-like receptors(TLRs). If pathogens cannot be eliminated, they may elicit chronic inflammation, which may be partly mediated via TLRs. Additionally, chronic inflammation has long been suggested to trigger tissue tumorous transformation. Inflammation, the seventh hallmark of cancer, may affect all phases of tumor development, and evade the immune system. Inflammation acts as a cellular stressor and may trigger DNA damage or genetic instability. Furthermore, chronic inflammation can provoke genetic mutations and epigenetic mechanisms that promote malignant cell transformation. Colorectal cancers in inflammatory bowel disease patients are considered typical examples of inflammation-related cancers. Although data regarding the role of TLRs in the pathomechanism of cancer-as-sociated colitis are rather conflicting, functionally these molecules can be classified as 'largely antitumorigenic' and 'largely pro-tumorigenic' with the caveat that the underlying signaling pathways are mainly context(i.e., organ-, tissue-, cell-) and ligand-dependent.Ferenc Sipos István Fri Miklós Constantinovits Zsolt Tulassay Gyrgyi Mzes 2014World Journal of Gastroenterology2014,20,36:9
3Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitisB using HBsAg and HBV DNA levels 显示文摘Rijckborst V Hansen BE Cakaloglu Y Ferenci P Tabak F Akdogan M Simon K Akarca US Flisiak R Verhey E Van Vuuren AJ Boucher CA ter Borg MJ Janssen HL 2010Hepatology2010,52,2:1
4Managing the career plateau显示文摘Ference T P Stoner J A F Warren E K 1977Academy of Management Review1977,,2:1
5Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels 显示文摘Rijckborst V Hansen BE Cakaloglu Y Ferenci P Tabak F Akdogan M Simon K Akarca US Flisiak R Verhey E Van Vuuren AJ Boucher CA ter Borg MJ Janssen HL 2010Hepatology2010,52,2:1
6Complete inhibition of P- gly- coprotein by simultaneous treatment with a distinct class of modu- lators and the UIC2 monoclonal antibody显示文摘Katalin G Ferenc F Zsoh B 2007J Pharm Exp Ther2007,320,1:1
7Determination of saquinavir in human plasma by high-performance liquid chroatography显示文摘HUY R H FERENC F YVONNE B 1997J Chromatogr B1997,694,:1
8Circulating and cardiac levels of apelin,the novel ligand of the orphan receptor APJ,in patients with heart failure显示文摘Gábor F Ferenc H István S 2003Biochem Biophys Res Commun2003,308,3:1
9Newer treatments for decompensated heart failure:Focus on levosimendan显示文摘Ferenc F 2009Drug Des Devel Ther2009,3,:1
10Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure 显示文摘G bor F Ferenc H Istv n S 2003Biochem and Biophys Research Communi2003,308,3:1
11Synthesis and ring-chain tautomerism of stereoisomeric 1,3-oxazines condensed with the cyclopentane ring显示文摘Ferenc F Kalevi P Jorma M 1987Tetrahedron1987,43,8:1
12Classeeic preconditioning decrease the harmful accumulation of nitric oxied during ischemia and reperfusionin rat hearts显示文摘Csaba C Zoltan S Ference F 1999Circulation1999,100,22:1
13Manufacturing synthesis of5-substituted phthalides显示文摘Ferenc F Angelika T Balazs al 2010Org Process Res Dev2010,14,3:1
14Telaprevir for retreatment of HCV infection 显示文摘Zeuzem S Andreone P Pol S Lawitz E Diago M Roberts S Foeaccia R Younossi Z Foster GR Horban A Ferenci P Nevens F Mullhaupt B Pockros P Terg R Shouval D van Hoek B Weiland O Van Heeswijk R De Meyer S Luo D Boogaerts G Polo R Picchio G Beumont M REALIZE Study Team 2011N Engl J Med2011,364,25:1
15Enzymatic method for the synthesis of blockbuster drug intermediates-synthesis of five-membered cyclic -v-amino acid and -y-lactam enantiomers 显示文摘ENIKO F FERENC F 2008Eur J Org Chem2008,31,2008:1
16Classic precondi-tioning decrease the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts 显示文摘Csonka C Zohan S Ferenc F 1999Circulation1999,100,22:1
17classeelc preconditioning decrease the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts显示文摘Csaba c Zoltan s Ference F 1999Circulation1999,100,2:1
18Newer treatments for deeompensated heart failure: focus on levosi- mendan显示文摘Ferenc F 2009Drug Des Devel2009,3,:1
19Managing the career plateau显示文摘Ference T P Stoner J A F Warren E K 1977Academy of Management Review1977,,2:1
20Telaprevir for retreatment of HCV infection显示文摘Zeuzem S Andreone P Pol S Lawitz E Diago M Roberts S Focaccia R Younossi Z Foster G R Horban A Ferenci P Nevens F Müllhaupt B Pockros P Terg R Shouval D Hoek B Weiland O Heeswijk R Meyer S Luo D Boogaerts G Polo R Picchio G Beumont M 2011N Engl J Med2011,364,25:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费